Investigational Site Number 840001

Boston, Massachusetts 02118

0 studies enrolling now · 6 studies all time

What they study most

Malignant Solid Tumors, Neoplasm Malignant, Solid Tumor Cancers, Solid Tumors, Systemic Sclerosis

Studies at this site

• Phase 1 Safety Testing of SAR405838 — Completed
• Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors — Completed
• Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid Tumors — Completed
• Proof of Biological Activity of SAR100842 in Systemic Sclerosis — Completed
• A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer — Completed
• A Study of Investigational SAR256212 in Combination With SAR245408 in Patients With Solid Tumor Cancers — Completed